endolysin has been researched along with mupirocin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, K; Idelevich, EA; Knaack, D; Kriegeskorte, A; Molinaro, S; Peters, G; Schleimer, N | 1 |
| Abdulamir, AS; Awni, AA; Hamed, ZO | 1 |
2 other study(ies) available for endolysin and mupirocin
| Article | Year |
|---|---|
Bactericidal activity of bacteriophage endolysin HY-133 against Staphylococcus aureus in comparison to other antibiotics as determined by minimum bactericidal concentrations and time-kill analysis.
Topics: Anti-Bacterial Agents; Daptomycin; Endopeptidases; Microbial Sensitivity Tests; Microbial Viability; Mupirocin; Recombinant Proteins; Staphylococcus aureus; Staphylococcus Phages | 2019 |
Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
Topics: Anti-Bacterial Agents; Bacteriophages; Burns; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Mupirocin; N-Acetylmuramoyl-L-alanine Amidase; Ointments; Staphylococcus aureus | 2023 |